Immunogenicity Study of the Influenza Vaccine in Adults

NCT00258934 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

978

Enrollment

INDUSTRY

Sponsor class

Conditions

Orthomyxoviridae Infections
Influenza

Interventions

BIOLOGICAL: Inactivated, split-virion influenza vaccine
BIOLOGICAL: Inactivated, split-virion, influenza virus

Sponsor

Sanofi Pasteur, a Sanofi Company